Endocrinology Book



Aka: Lorcaserin, Belviq, Belviq XR
  1. See Also
    1. Medications Associated with Weight Gain
    2. Orlistat (Xenical)
    3. Phentermine (Ionamin, Fastin)
    4. Phentermine and Topiramate (Qsymia, Qnexa)
    5. Obesity
    6. Obesity in Children
    7. Obesity Evaluation
    8. Obesity Measurement (or Obesity Screening)
    9. Obesity Risk (or Obesity Comorbid Conditions)
    10. Obesity Management
    11. Obesity Medication
    12. Dietary Supplements in Obesity
    13. Exercise in Obesity
    14. Obesity Resources
  2. Background
    1. Released in U.S. in 2013
    2. Removed from market February 2020 in U.S. due to cancer risk
      1. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market
  3. Efficacy
    1. Weight loss is 7 pounds more than Placebo in one year
    2. Weight loss of at least 5% in up to 47% of patients at one year
  4. Mechanism
    1. Serotonin 2C (5HT-2C) agonist that increases satiety
    2. Active at pro-opiomelanocortin (POMC) Neurons of the Hypothalamus
    3. POMC is cleaved into a-Melanocyte Stimulating Hormone (MSH)
    4. MSH binds Hypothalamus melanocortin 4 receptors, resulting in decreased food intake
    5. Thomsen (2008) J Pharmacol Exp Ther 325(2): 577-87 [PubMed]
  5. Dosing
    1. Lorcaserin (Belviq) 10 mg orally twice daily
    2. Belviq XR preparation available for once daily use in 2017
    3. Stop medication if 5% weight loss is not achieved at 12 weeks
  6. Adverse Effects
    1. Cancer Risk
      1. https://www.fda.gov/drugs/drug-safety-and-availability/safety-clinical-trial-shows-possible-increased-risk-cancer-weight-loss-medicine-belviq-belviq-xr
    2. No associated valvulopathy
      1. Lorcaserin has 100 fold greater neurologic 5HT-2C affinity over cardiac valve 5HT-2B affinity
    3. Well tolerated
    4. More specific, and does not appear to carry same valvular heart disease risks as with fenfluramine
    5. Constipation
    6. Cough
    7. Dry Mouth
    8. Fatigue
    9. Nausea
    10. Hypoglycemia
  7. Drug Interactions
    1. Serotonergic medications (e.g. SSRI, Dextromethorphan)
      1. Serotonin Syndrome risk
  8. References
    1. (2013) Presc Lett 20(7): 37
    2. Erlandson (2016) Am Fam Physician 94(5): 361-8 [PubMed]
    3. Fidler (2011) J Clin Endocrinol Metab 96:3067-3077 [PubMed]
Medication Costs
belviq (on 9/8/2016 at Medicaid.Gov Pharmacy Drug pricing)
BELVIQ 10 MG TABLET $3.89 each
BELVIQ XR 20 MG TABLET $7.73 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

lorcaserin (C2350948)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C506658
English Lorcaserin, (1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, lorcaserin, LORCASERIN
Derived from the NIH UMLS (Unified Medical Language System)

Belviq (C3485407)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C506658
English Belviq
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree